nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.0627	0.464	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.0188	0.139	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.0123	0.0914	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.00861	0.0638	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00749	0.0555	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00494	0.0366	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00334	0.0247	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00277	0.0205	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GNS—peripheral nervous system neoplasm	0.00241	0.0179	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NME1—peripheral nervous system neoplasm	0.00231	0.0171	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—COX2—peripheral nervous system neoplasm	0.00223	0.0165	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00146	0.0108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BCHE—peripheral nervous system neoplasm	0.00123	0.00914	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00118	0.00872	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TH—peripheral nervous system neoplasm	0.00116	0.00859	CbGpPWpGaD
Icosapent ethyl—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00126	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00126	CcSEcCtD
Icosapent ethyl—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00125	CcSEcCtD
Icosapent ethyl—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00107	0.00124	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00124	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00124	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00123	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00107	0.00123	CcSEcCtD
Icosapent ethyl—Oedema—Vincristine—peripheral nervous system neoplasm	0.00107	0.00123	CcSEcCtD
Icosapent ethyl—Infection—Vincristine—peripheral nervous system neoplasm	0.00106	0.00122	CcSEcCtD
Icosapent ethyl—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00106	0.00122	CcSEcCtD
Icosapent ethyl—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00122	CcSEcCtD
Icosapent ethyl—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00121	CcSEcCtD
Icosapent ethyl—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00121	CcSEcCtD
Icosapent ethyl—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00121	CcSEcCtD
Icosapent ethyl—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00104	0.0012	CcSEcCtD
Icosapent ethyl—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00104	0.0012	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.0012	CcSEcCtD
Icosapent ethyl—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00104	0.0012	CcSEcCtD
Icosapent ethyl—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Icosapent ethyl—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Icosapent ethyl—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00103	0.00119	CcSEcCtD
Icosapent ethyl—Back pain—Etoposide—peripheral nervous system neoplasm	0.00102	0.00118	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00118	CcSEcCtD
Icosapent ethyl—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00102	0.00118	CcSEcCtD
Icosapent ethyl—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00102	0.00117	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00117	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00116	CcSEcCtD
Icosapent ethyl—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00116	CcSEcCtD
Icosapent ethyl—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000986	0.00114	CcSEcCtD
Icosapent ethyl—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000983	0.00114	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000983	0.00114	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000981	0.00113	CcSEcCtD
Icosapent ethyl—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000973	0.00113	CcSEcCtD
Icosapent ethyl—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000973	0.00112	CcSEcCtD
Icosapent ethyl—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000971	0.00112	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000971	0.00112	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.00112	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000969	0.00112	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000969	0.00112	CcSEcCtD
Icosapent ethyl—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000965	0.00112	CcSEcCtD
Icosapent ethyl—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000965	0.00112	CcSEcCtD
Icosapent ethyl—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000964	0.00111	CcSEcCtD
Icosapent ethyl—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000961	0.00111	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000955	0.0011	CcSEcCtD
Icosapent ethyl—Malaise—Etoposide—peripheral nervous system neoplasm	0.000954	0.0011	CcSEcCtD
Icosapent ethyl—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00095	0.0011	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000948	0.00702	CbGpPWpGaD
Icosapent ethyl—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000945	0.00109	CcSEcCtD
Icosapent ethyl—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000945	0.00109	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000943	0.00109	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000942	0.00109	CcSEcCtD
Icosapent ethyl—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000942	0.00109	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000936	0.00108	CcSEcCtD
Icosapent ethyl—Infection—Cisplatin—peripheral nervous system neoplasm	0.000936	0.00108	CcSEcCtD
Icosapent ethyl—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000935	0.00108	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000932	0.00108	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00093	0.00688	CbGpPWpGaD
Icosapent ethyl—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000929	0.00107	CcSEcCtD
Icosapent ethyl—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000928	0.00107	CcSEcCtD
Icosapent ethyl—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000928	0.00107	CcSEcCtD
Icosapent ethyl—Rash—Topotecan—peripheral nervous system neoplasm	0.000927	0.00107	CcSEcCtD
Icosapent ethyl—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000926	0.00107	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000926	0.00107	CcSEcCtD
Icosapent ethyl—Cough—Etoposide—peripheral nervous system neoplasm	0.000923	0.00107	CcSEcCtD
Icosapent ethyl—Rash—Tretinoin—peripheral nervous system neoplasm	0.00092	0.00106	CcSEcCtD
Icosapent ethyl—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00092	0.00106	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00092	0.00106	CcSEcCtD
Icosapent ethyl—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000919	0.00106	CcSEcCtD
Icosapent ethyl—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000919	0.00106	CcSEcCtD
Icosapent ethyl—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000919	0.00106	CcSEcCtD
Icosapent ethyl—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000916	0.00106	CcSEcCtD
Icosapent ethyl—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000913	0.00106	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.00105	CcSEcCtD
Icosapent ethyl—Pain—Vincristine—peripheral nervous system neoplasm	0.000911	0.00105	CcSEcCtD
Icosapent ethyl—Constipation—Vincristine—peripheral nervous system neoplasm	0.000911	0.00105	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000911	0.00105	CcSEcCtD
Icosapent ethyl—Rash—Melphalan—peripheral nervous system neoplasm	0.000908	0.00105	CcSEcCtD
Icosapent ethyl—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000907	0.00105	CcSEcCtD
Icosapent ethyl—Chest pain—Etoposide—peripheral nervous system neoplasm	0.0009	0.00104	CcSEcCtD
Icosapent ethyl—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000898	0.00104	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.00104	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.00104	CcSEcCtD
Icosapent ethyl—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00089	0.00103	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000886	0.00102	CcSEcCtD
Icosapent ethyl—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000874	0.00101	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000871	0.00101	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000868	0.001	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000866	0.001	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000863	0.000998	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.000998	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000858	0.000992	CcSEcCtD
Icosapent ethyl—Infection—Etoposide—peripheral nervous system neoplasm	0.000857	0.000991	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00099	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000856	0.000989	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000851	0.000984	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000851	0.000984	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000851	0.000984	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000842	0.000974	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000842	0.000974	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00084	0.000971	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000834	0.000965	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000834	0.000964	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000829	0.000958	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000823	0.000951	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00082	0.000948	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000819	0.000947	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000818	0.000946	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000813	0.00094	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000806	0.000932	CcSEcCtD
Icosapent ethyl—Pain—Cisplatin—peripheral nervous system neoplasm	0.000806	0.000931	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000803	0.000929	CcSEcCtD
Icosapent ethyl—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.000917	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.000916	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00091	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00091	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00091	CcSEcCtD
Icosapent ethyl—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000782	0.000904	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000776	0.000898	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.000892	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000769	0.00089	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000887	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000767	0.000887	CcSEcCtD
Icosapent ethyl—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000764	0.000884	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000882	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000759	0.000877	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000759	0.000877	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000758	0.000877	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.000875	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000752	0.000869	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00075	0.000867	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000745	0.000861	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000745	0.000861	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—peripheral nervous system neoplasm	0.000738	0.000853	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—peripheral nervous system neoplasm	0.000738	0.000853	CcSEcCtD
Icosapent ethyl—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000731	0.000845	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000727	0.000841	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000827	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000823	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000711	0.000822	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.000821	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000816	CcSEcCtD
Icosapent ethyl—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000705	0.000815	CcSEcCtD
Icosapent ethyl—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000703	0.000813	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000702	0.000811	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000702	0.000811	CcSEcCtD
Icosapent ethyl—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000697	0.000806	CcSEcCtD
Icosapent ethyl—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.000805	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000683	0.000789	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000682	0.000789	CcSEcCtD
Icosapent ethyl—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000677	0.000783	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000676	0.000781	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000781	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000778	CcSEcCtD
Icosapent ethyl—Rash—Vincristine—peripheral nervous system neoplasm	0.000672	0.000777	CcSEcCtD
Icosapent ethyl—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000671	0.000776	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.000765	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000658	0.000761	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.00073	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000723	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000619	0.000716	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—peripheral nervous system neoplasm	0.000611	0.000706	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000611	0.000706	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000703	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000602	0.000696	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000599	0.000693	CcSEcCtD
Icosapent ethyl—Rash—Cisplatin—peripheral nervous system neoplasm	0.000594	0.000687	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000593	0.000686	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000685	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000671	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000663	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000571	0.00066	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000654	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000651	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.000644	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000636	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000549	0.000634	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000634	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—peripheral nervous system neoplasm	0.000544	0.000629	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000544	0.000629	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000621	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000618	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000616	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000615	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000531	0.000613	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000602	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000598	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000592	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000588	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000583	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000583	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000583	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000576	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000572	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000494	0.000571	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.00057	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000569	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000559	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000559	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000557	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000556	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000553	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—peripheral nervous system neoplasm	0.000476	0.00055	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000547	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000546	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000541	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.00054	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.00054	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.00054	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000533	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000533	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000528	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000518	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000518	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000514	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00051	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000509	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000506	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000505	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.0005	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000499	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000493	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000492	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000486	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000483	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000478	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000478	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000472	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000468	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000461	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000461	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000456	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.00045	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000447	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000443	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000443	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000442	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000426	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000409	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000401	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000396	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000371	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00037	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000366	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000356	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000353	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000352	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000342	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000329	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000326	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000326	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AKT1—peripheral nervous system neoplasm	0.000256	0.00189	CbGpPWpGaD
